For the majority of the independent variables (e.g. age, year of diagnosis, HR status, HER2 status tumor grade, stage of tumor, histology, chemotherapy), the hazard ratio was consistent between chart review and algorithm-estimated data. This evidence concerns the gene ERBB2 and neoplasm.